BioSpace News Archive

Vivera Pharmaceuticals, Inc., a California -based pharmaceutical company focused on putting patients first, announces the launch of their point-of-care ready rapid serology tests. Bringing man

ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is pleased to announce the publication of a clinical study highlighting their most recent award-winning breakthrough product, INhance Post-Injection Serum with TriHex Technology®.

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the pricing of its previously announced public offering for the offering of 2,175,000 shares of common stock of the Company at a price to the public of $11.40 per share

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understanding with Cannomed Medical Cannabis Industries Ltd. (TASE: CNMD), to develop cannabis cultivars targeted to treat c

Tychan, a Singapore-based clinical-stage biotechnology company, is initiating Phase 1 clinical trials to evaluate TY027, the first novel monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19.

In April 2020, in the midst of the COVID-19 pandemic, healthcare professional services declined 68 percent in utilization and 48 percent in revenue based on total estimated in-network amounts compared to April 2019 nationally.

EpicentRx, Inc., a clinical-stage pharmaceutical company on a mission to advance its portfolio of small molecule and virus-based immunotherapies for the treatment of patients with cancer and other diseases of high unmet need such as COVID-19, today announced the appointment of Dr. Franck Brinkhaus as President in addition to his current role as Chief Financial Officer.

The Muscular Dystrophy Association invites you to join a special virtual conversation on Facebook Live featuring MDA Medical Consultant Dr. John W. Day and MDA Director of Care Center Programs, Marydeth Guerin

Health Canada is advising Canadians that the following hand sanitizers may pose health risks.

Strategikon Pharma, developer of the industry’s only SaaS platform for clinical trial business operations, today announced the release of Clinical Maestro LEAD™ for ongoing trial budget management.